SG Americas Securities LLC Buys 506,395 Shares of Masimo Corporation $MASI

SG Americas Securities LLC grew its stake in shares of Masimo Corporation (NASDAQ:MASI) by 3,082.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 522,824 shares of the medical equipment provider’s stock after buying an additional 506,395 shares during the period. SG Americas Securities LLC owned 0.97% of Masimo worth $92,995,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Evolve Private Wealth LLC bought a new position in shares of Masimo in the first quarter valued at approximately $305,000. Diversified Trust Co bought a new stake in Masimo during the 1st quarter worth approximately $833,000. Corient Private Wealth LLC increased its holdings in Masimo by 1.2% during the 4th quarter. Corient Private Wealth LLC now owns 340,230 shares of the medical equipment provider’s stock worth $44,250,000 after acquiring an additional 4,015 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in Masimo in the 4th quarter worth approximately $116,000. Finally, Pacer Advisors Inc. lifted its stake in Masimo by 21.1% in the 4th quarter. Pacer Advisors Inc. now owns 7,360 shares of the medical equipment provider’s stock worth $957,000 after purchasing an additional 1,280 shares in the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Price Performance

MASI stock opened at $179.95 on Monday. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The company’s 50 day moving average is $178.84 and its 200 day moving average is $161.91. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. Masimo Corporation has a 1-year low of $125.94 and a 1-year high of $179.99.

Wall Street Analyst Weigh In

MASI has been the subject of several analyst reports. Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Finally, Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Nine investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.